ATM mutations are rare in familial chronic lymphocytic leukemia

Blood

Volumn 100, Issue 2, 2002, Pages 603-609

  Yuille, Martin R ^a   Condie, Alison ^a   Hudson, Chantelle D ^a   Bradshaw, Paul S ^a   Stone, Elaine M ^a   Matutes, Estella ^a   Catovsky, Daniel ^a   Houlston, Richard S ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; FAMILIAL DISEASE; FEMALE; GENE CLUSTER; GENE FREQUENCY; GENE MUTATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PRIORITY JOURNAL;

EID: 0037100516     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V100.2.603     Document Type: Article

References (40)

1. Biology of chronic lymphocytic leukemia
2. The epidemiology of chronic lymphocytic leukemia
3. Familial chronic lymphocytic leukemia: A survey and review of published studies
4. Chromosome-breakage syndromes: Different genes, different treatments, different cancers
5. Leukemia and lymphoma in ataxia telangiectasia
6. Localization of an ataxia-telangiectasia gene to chromosome 11q 22-23
7. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species
8. A single ataxia-telangiectasia gene with a product similar to Pl-3 kinase
9. Molecular analysis of mutations in the hprt gene in circulating lymphocytes from normal and DNA-repair-deficient donors
10. High frequency of spontaneous translocations revealed by FISH in cells from patients with the cancer-prone syndromes ataxia telangiectasia and Nijmegen breakage syndrome
11. The rejoining of double-strand breaks in DNA by human cell extracts
12. High spontaneous intrachromosomal recombination rates in ataxia-telangiectasia
13. Ataxia-telangiectasia, cancer and the pathobiology of the ATM gene
14. Comparative human cellular radiosensitivity, II: The survival following gamma-irradiation of unstimulated (G0) T-lymphocytes, T-lymphocyte lines, lymphoblastoid cell lines and fibroblasts from normal donors, from ataxia-telangiectasia patients and from ataxia-telangiectasia heterozygotes
15. A comparison of the radiosensitivity of lymphocytes from normal donors, cancer patients, individuals with ataxia-telangiectasia (A-T) and A-T heterozygotes
16. ATM heterozygote cells exhibit intermediate levels of apoptosis in response to streptonigrin and etoposide
17. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer
18. Breast and other cancers in families with ataxiatelangiectasia
19. Inactivation of ataxia telangectasia mutated gene in B-cell chronic lymphocytic leukemia
20. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia
21. ATM mutations in B-cell chronic lymphocytic leukemia
22. Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia
23. Linkage analysis for ATM in familial chronic lymphocytic leukemia
24. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukemia
25. Characterization of ATM mutations in 66 ataxia telangiectasia families
26. The ATM gene and susceptibility to breast cancer: Analysis of 38 breast tumors reveals no evidence for mutation
27. Identification of germline missense mutations and rare allelic variants in the ATM gene in early-onset breast cancer
28. New mutations, polymorphisms, and rare variants in the ATM gene detected by a novel SSCP strategy
29. Mutations at the ataxia-telangiectasia locus and clinical phenotypes of A-T patients
30. A polymorphism in the ATM gene modulates the penetrance of hereditary non-polyposis colorectal cancer
31. Ataxia-telangiectasia: Mutations in cDNA detected by protein truncation screening
32. Splicing defects in the ataxia-telangiectasia gene, ATM: Underlying mutations and phenotypic consequences
33. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: Expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer
34. Cancer risks in A-T heterozygotes
35. Missense mutations at ATM gene and cancer risk
36. Cancer risk in ATM heterozygotes: A model of phenotypic and mechanistic differences between missense and truncating mutations
37. A polymorphism in the ATM gene modulates the penetrance of hereditary non-polyposis colorectal cancer
38. The ATM gene and breast cancer: Is it really a risk factor?